Optimizing COPD care in primary care: going for Silver or for Gold?

Completed

• Conditions: COPD; 10038716

• Registration Number: NL-OMON31653
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 720

Inclusion Criteria

COPD patients (FEV1/FVC < 70% predicted) Gold I - IV; age: 40-75 yrs; smokers.

Exclusion Criteria

not familiar with the Dutch language
patients in the end stage of a disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary study endpoint: point prevalence after 24 months, measured by<br /><br>self-reported smoking and biochemical verification (urinary cotinine<br /><br>measurement).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary study endpoint: abstinence after 12 en 24 months, functional status,<br /><br>quality of life, attitude, social stimulation, self-efficacy, patiënt<br /><br>perception, motivation, smoking habits and pulmonary function.</p><br>